Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

Monitoring and supplementing maternal 25(OH) vitamin D levels in patients with lupus within the 40-59 ng/mL range are crucial while preventing excessive supplementation, this study suggested.

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

Preconception predictors of adverse pregnancy outcomes among women with SLE include previous lupus nephritis, chronic hypertension, SLE disease activity, and APS.

The following is a summary of “Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus,” ...

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...

Recent meta-analysis conducted by Abheiden et al. aimed to determine the proportions of spontaneous and indicated preterm ...

New research suggests that higher daily intakes of ultraprocessed foods (UPFs) are associated with a higher risk of ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...